INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands |
3 Months Ended |
9 Months Ended |
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
| Cash flows from operating activities: |
|
|
|
|
| Net loss |
$ (6,858)
|
$ (5,336)
|
$ (19,259)
|
$ (18,267)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
| Depreciation |
70
|
67
|
215
|
190
|
| Stock-based compensation related to options granted to employees and directors |
395
|
196
|
1,305
|
726
|
| Finance lease expense (income) |
(34)
|
8
|
(646)
|
(182)
|
| Decrease in other accounts receivable and prepaid expenses |
457
|
516
|
1,081
|
1,243
|
| Increase (decrease) in trade payables |
1,103
|
(261)
|
2,695
|
(2,678)
|
| Decrease in other accounts payable and accrued expenses |
17
|
(1,650)
|
(63)
|
(1,789)
|
| Total net cash used in operating activities |
(4,850)
|
(6,460)
|
(14,672)
|
(20,757)
|
| Cash flows from investing activities: |
|
|
|
|
| Purchase of property and equipment |
(1)
|
(237)
|
(29)
|
(295)
|
| Changes in short-term deposit |
(10)
|
1,933
|
(11)
|
1,915
|
| Total net cash used in investing activities |
(11)
|
1,696
|
(40)
|
1,620
|
| Cash flows from financing activities: |
|
|
|
|
| Proceeds from exercise of options |
|
|
|
5
|
| Proceeds from issuance of shares in at-the-market (ATM) offering (Note 7) |
|
(106)
|
|
6,998
|
| Total net cash provided by (used in) financing activities |
|
(106)
|
|
7,003
|
| Decrease in cash and cash equivalents |
(4,861)
|
(4,870)
|
(14,712)
|
(12,134)
|
| Cash and cash equivalents at the beginning of the period |
9,005
|
30,565
|
18,856
|
37,829
|
| Cash and cash equivalents at end of the period |
$ 4,144
|
$ 25,695
|
$ 4,144
|
$ 25,695
|